MetaCap

AgomAb Therapeutics NV Statistics

NASDAQ: AGMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

5.45-0.17 (-3.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AgomAb Therapeutics NV by the numbers

AgomAb Therapeutics NV has a market capitalization of $268.4 million based on 49.25M shares outstanding. With trailing EPS of $-2.08, AgomAb Therapeutics NV is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 37.3% below its 50-day average and 53.4% below its 200-day average.

Average daily trading volume is 208.99K shares, or about $1.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AGMB valuation vs. peer median

AGMB compared with the median of 8 peer companies
MetricAGMBPeer medianDifference
Market cap$268.40M$258.70M+4%
Avg. volume208.99K886.23K-76%

Peer median across 8 companies: KYTX, AGEN, OCGN, EIKN, DTIL, SABS, EDIT, LXEO.

Valuation

Price and trading

Previous close
5.62
Open
5.51
Day range
5.39 – 5.78
52-week range
5.39 – 17.82
Beta
—
Volume
188.94K

Dividends and events

Additional statistics

Market Cap
268.40M
Forward Pe
-2.70
Eps
-2.08
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.82
Week52 Low
5.39
Avg Volume
208.99K
Shares Outstanding
49.25M
Ma50
8.70
Ma200
11.69
Pct From52w High
-69.42%
Pct From52w Low
1.11%

Related